Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The problem in the market may be much deeper. Amarin invester's get the short stick.
Trump's Swelling Budget Deficits Lead to Record Treasury-Bond Sales
President Donald Trump's $1.5 trillion of tax cuts in December, designed to stimulate growth, have decimated government revenue, ballooning the federal budget deficit and forcing Treasury Department officials to cover the gap by borrowing money in unprecedented amounts. Investors appear unfazed -- so far.
The feds make the decisions about bond issues and there purpose.
Denial is a wonderful thing! Only one has escaped a prison term.
He never had sex or a date with a famous porn star. LMAO
He never knew about the payment to keep her quite. He didn't know the hush money payment came from campaign financing. Tip of the iceberg....
POTUS is the king of falsehoods! :>) Criminal activity is not a forgivable presidential activity. Seems he was well aware of these activities.
See he is wining all day long and vomiting for nothing. We will probably be back where we started.
Down we go... wait up we go...yikes.
There reaosning is so that they have a tool in the arsenal. At zero percent nothing they can do, they can't lower it any further. So wa la they need to raise it so they can lower it. They should work on there debt that's the real problem.
Sorry I just browsed the article, I'm working now now. Great article you wrote, way better than most of the rubbish that is printed these days.
To late to add this link?
EPA
Actually there were indicators that predicted this drop like SDS ProShares UltraShort S&P500. There were two very large buys mid day and later in the afternoon two days ago, I got out early morning yesterday, but thought about sticking around. Someone or entity new what was going to happen. These are pro plays. These guys made big easy money.
FFS failed to catch some sign's and not to mention the minor interest rise was a sure thing yesterday.
Thanks!
Biologic Basis of EPA to Reduce Atherosclerosis Burden. Way ahead of the curve - great speaker. Dr. Nissen would be wise to listen to this video.
R. Preston Mason, PhD
Cardiovascular Division
Brigham and Women’s Hospital
Scientific Director and Founder
Elucida Research
Biologic Bassis of EPA to Reduce Artherosclerosis
Probably a benign liquid sugar water what ever you wan to call it!
I find Dr. Nissen's statements very disturbing about the rise of LDL-C in Reduce-It's trial he said 10%. He said certainly caused by mineral oil and blurted out considerable data showed that mineral oil prevented Statin's absorption a getting into the blood steam. I have found none. Are these straight out lies? I think so.
Dr. Nissen AHA - 2018
5:20 minutes into video about Reduce-It.
Kiwi what was the placebo?
Looks like the meager hike had more of an impact than expected! But as usual an over reaction.
Well it's a good day so far, hope we have a nice CC next March. I suspect we blow away estimated revs.
Yes agree 100 percent, the European market is made for us. I hope it finally register EPA blood level's are important for over all health and lowering CVD risk.
Yes a couple of days ago I sold my around 3700 trading shares bought back more around 5000 at the lower price this morning.
My portfolio hardly flinch on the expected hike- I was clever and bought back shares of AMRN this morning, plus a 1000 extra. Yipeeee.
After a quick calculation, we will blow away analysts expected revs during CC in March.
So whats your prediction for tomorrows opening on the DOW?
This sell off just doesn't make sense - we have a (safety stock) that will beat last years matching quarterin revenues by quite a bit! So why the sell off? Well the silver lining is, I will buy quite a few more shares back once this settles.
I waiting myself - I have my trading lot 3,800 sale I made at ~15.90 in my roth rollover IRA. So waiting to buy back soon. I don't want to wait any longer than Friday. Watching the S&P 500/NAS closely...
Doesn't make sense to do this, when fuel ethanol can be produced with renewable biomass sources. Not even sure this make sense in China other than to give meaning to the use of coal for fuel. Seems like a dead end approach.
Best time to make a strategic plays with some short time trades with SH, SDS symbols. Balance out the portfolio.
They have fly's (bugs) on the wall. :>)
J.L. deserve a little leeway regarding ego's. He has provide the fuel for a successful AMRN investment. He knew more about the efficacy of EPA long before most physicians out there. Your new here, so J.L. is way ahead of the curve compared to you!
J.L. Looks like J&J got nailed over the baby Powder issue. I believe you mention this problem way back when if I remember correctly.
Baby Powder
Just another medical committee that does seem to understand the difference between dosages and effectiveness. The should be sent back to medical school. Not to mention they know nothing about the importance of EPA/AA ratios. The Japanese Scientists are clearly way ahead of these so called experts.
Definition of EXPERT.
Someone who knows more and more, about less and less.
Actually I was looking into Amarin long ago. The tool that tracked my stocks I had installed on my P.C. failed. So lost my list and lost track of Amarin. I discovered Amarin after Anchor results, which hit the news.So started to invest around this time. I agree it caught my interest because it was a non cancer drug. I was ready to give up on Biomed investments, Amarin was still a long hard road though.
Certainly don't touch cancer stocks any longer.
My last cancer stock was PPHM like 5 years ago, I got out long before Sunrise trial started! Many poster fell in love with Bavi and never left, they got screwed big time. Sunrise lung cancer phase III failed.
I learned about the rule and totally agree with it, stayed away from Cancer Drug Development stocks. Even companies with higher market caps still have a high rates of failures in this arena.
Where's the beef?
Maybe today.
The sponsor of the trial should have known better! They are highly respected physicians. If they don't have have an understanding of O3 dosage levels and effect, they don't belong in the medical research field.
JoAnn Elisabeth Manson, MD, PHD
Good job VuBru, hope it works out for you!
Exactly why FDA needs to approve the Anchor label. Lowers the bar for Insurance Coverage. I hope Amarin takes this approach, opening the market available until Reduce-It sNDA is approved. The niche can be filled. I'm in the same boat with United HC, BC/BS covered even off label.
The statement I wrote was really directed at the company spokesman, not about the site content, which I agree doesn't need to be to technical.
It's nice for J.T. to enjoy some lime light, but I would like to see one of our medically trained staff speaking about Reduce-It and EPA/AA ratios and such at the dog and pony show's. I mean listening to a CEO/CPA explain a medical treatment seems out off place.
Later on, I hope Amarin will schedule some state to state medical conferences and cover the detail's of Reduce-It and having a frank discussion with physicians around the country. I think this will help educate the P.C.P out in the field regarding Vascepa 'EPA' and Laboratory Testing that should be included during treatment perhaps once a year. It would be nice to see a discussion going on in the medical community about this subject, which oddly is missing from our western culture. It's funny how many years were spent on researching CVD treatments using niacin, fibrates, Vitamin B and E others, with the chemical (EPA) which researchers should have been testing as a CVD drug was right in front of there face.
I hope I conveyed my thoughts properly! Not the best writer..